NEWS | CLINICAL TRIALS

   

KEEL Radio News - LSU Health Shreveport starts two promising COVID Clinical Trials - image of scientist in the lab

LSU Health Shreveport / Feist-Weiller Cancer Center is a strategic partner with MD Anderson and the Cancer Focus Fund LP working to advance promising cancer therapies.

Read More about March Biosciences and Cancer Focus Fund Announce $4.8 Million Investment to Support a Phase 2 Clinical Trial of Novel CAR-T Therapy for T-Cell Lymphoma (opens in new window/tab)
Nobel Prize-Winning Scientist Explains Why New Study in New England Journal of Medicine May Point To Nitric Oxide as Successful Treatment For COVID-19

Keith Scott, MD, MSc, FCCM, Professor and the clinical trial's Principal Investigator for the nitric oxide trials at LSU Health Shreveport says, "Teasing out the influence of naturally produced NO on this process is difficult. What I am very encouraged about is the demonstration of virus in the endothelial cells of the lung tissue."

Read More about Nobel Prize-Winning Scientist Explains Why New Study in New England Journal of Medicine May Point To Nitric Oxide as Successful Treatment For COVID-19 (opens in new window/tab)
COVID-19 patients develop the antibody at different intervals depending on virus attack

KTBS 3 - "We will confirm that they can detect the novel coronavirus, and then we will determine the amount. And we provide that information back to LifeShare Blood Center so that LifeShare can then make decisions about which plasma they will send out when requested by hospitals," Dr. Matthew Woolard said.

Read More about COVID-19 patients develop the antibody at different intervals depending on virus attack (opens in new window/tab)
The First Major Treatment could come from Shreveport

“We are excited to be approved for this early intervention treatment aimed at stopping the progression of the virus which gives patients an improved chance of recovering quickly by preventing the virus from worsening. This treatment will be especially important should we see an increase in the number of COVID-19 positive patients," Dr. Keith Scott said.

Read More about The First Major Treatment could come from Shreveport (opens in new window/tab)
WWL News image of coronavirus

Research from LSU Health Shreveport has shown that nitric oxide is a strong protector against tissue hypoxia. “It’s just really a raging phenomenon that occurs in the lung and if we can just calm that down a little bit and allow the body’s natural systems to come in an heal it, that’s the real goal,” said Scott.

Read More about LSU Health Shreveport testing if inhaled nitric oxide can fight COVID-19 (opens in new window/tab)

CONTACT CLINICAL TRIALS

Office Location
Monday - Friday ( 8:00am - 4:30pm)
LSU Health Shreveport
Admin Building 2nd Floor
1501 Kings Highway
Shreveport, LA 71103

Phone: (318) 675-8306
Email:  ctmt@lsuhs.edu

Text for Seal: %22Full AAHRPP Accreditation - Association for the Accreditation of Human Research Protection Programs, Inc.%22